DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Tue, 12 May · 17:03 IST

Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Auditors of the company.

Auditor Resigned MidtermManagement Changes View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1267.50
prior close
₹1245.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.5+1.7+2.1+2.7+6.0+5.0+5.2+4.2+3.4+0.1+0.9-2.4
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories Limited has notified the NSE about a change in the company's auditors. Auditor changes in listed companies typically require shareholder approval and are governed by regulatory guidelines on rotation and independence. Such changes can occur due to mandatory rotation requirements, completion of tenure, or mutual agreement between the company and the audit firm. The filing details the outgoing and incoming auditors along with the rationale for the transition.

Likely market impact

Auditor changes are routine governance events but signal careful attention to audit quality and independence. Unless there is a reported disagreement or governance concern flagged, the market impact is generally neutral to slightly positive as it may enhance audit freshness.